newsfilter
← Latest News
Business Wire·

Vir Biotechnology Announces Pricing of Public Offering of Common Stock

Vir Biotechnology, Inc. (NASDAQ:VIR), a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and